Biofrontera Inc. Amortization of Acquisition Costs
Biofrontera Inc. (BFRI) reported Amortization of Acquisition Costs of $300.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfAcquisitionCosts · last filed 2025-03-20
- Biofrontera Inc. amortization of acquisition costs for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Biofrontera Inc. amortization of acquisition costs for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- Biofrontera Inc. amortization of acquisition costs for the quarter ending 2023-12-31 was $100.00K.
- Biofrontera Inc. amortization of acquisition costs for the quarter ending 2023-09-30 was $100.00K.
- Biofrontera Inc. amortization of acquisition costs for fiscal 2024 was $300.00K, a 25.00% decline from fiscal 2023.
- Biofrontera Inc. amortization of acquisition costs for fiscal 2023 was $400.00K.
| Period end | Amortization of Acquisition Costs 3 month | Amortization of Acquisition Costs 6 month | Amortization of Acquisition Costs 9 month | Amortization of Acquisition Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $100.00K derived: sum of 2 quarters · filed 2025-03-20 | $300.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-14 | $300.00K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $200.00K derived: sum of 2 quarters · filed 2025-03-20 | $400.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-14 | $300.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |